Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H9N |
| Molecular Weight | 155.1959 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1=CC=C(C=C1)C2=CC=NC=C2
InChI
InChIKey=JVZRCNQLWOELDU-UHFFFAOYSA-N
InChI=1S/C11H9N/c1-2-4-10(5-3-1)11-6-8-12-9-7-11/h1-9H
| Molecular Formula | C11H9N |
| Molecular Weight | 155.1959 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pentacarbonyl(4-phenylpyridine)tungsten(0) and pentacarbonyl(2-phenylpyridine)chromium(0). | 2001 Apr |
|
| Tetra-mu-acetato-kappa2O:O'-bis[(4-phenylpyridine-kappaN)copper(II)]. | 2002 Apr |
|
| Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists. | 2002 Aug 1 |
|
| The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization. | 2002 Jun 21 |
|
| Tuning the electronic structures of platinum(II) complexes with a cyclometalating aryldiamine ligand. | 2004 Jan 26 |
|
| Richness of isomerism in labile octahedral Werner-type cobalt(II) complexes demonstrated by 19F NMR spectroscopy: structure and stability. | 2004 Sep |
|
| Autotoxicity, methylation and a road to the prevention of Parkinson's disease. | 2005 Jan |
|
| Parkinson's disease: the first common neurological disease due to auto-intoxication? | 2005 Mar |
|
| Rhenium(V) complexes with thiolato and dithiolato ligands: synthesis, structures, and monomerization reactions. | 2005 May 16 |
|
| Simple chip-based interfaces for on-line monitoring of supramolecular interactions by nano-ESI MS. | 2005 Oct |
|
| Mass spectrometric studies on 4-aryl-1-cyclopropyl-1,2-dihydropyridinyl derivatives: an examination of a novel fragmentation pathway. | 2006 Dec |
|
| N-Phenyl-N-{4-[5-(4-pyrid-yl)-1,3,4-oxadiazol-2-yl]phen-yl}aniline. | 2007 Dec 12 |
|
| The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells. | 2007 Feb |
|
| Dissecting the thermodynamics and cooperativity of ligand binding in cytochrome P450eryF. | 2007 Feb 21 |
|
| Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. | 2007 Jan 15 |
|
| Synthesis, growth and characterization of a new nonlinear optical material: 4-phenylpyridinium hydrogen squarate (4PHS). | 2008 Apr |
|
| Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. | 2008 May 28 |
|
| Regioselectivity and stereoselectivity of dioxygenase catalysed cis-dihydroxylation of mono- and tri-cyclic azaarene substrates. | 2008 Nov 7 |
|
| 1H, 13C and 15N nuclear magnetic resonance coordination shifts in Au(III), Pd(II) and Pt(II) chloride complexes with phenylpyridines. | 2009 Aug |
|
| Syntheses, structures and magnetic properties of a family of metal carboxylate polymers via in situ metal-ligand reactions of benzene-1,2,3-tricarboxylic acid. | 2009 Feb 28 |
|
| Thermal- and light-induced spin crossover in novel 2D Fe(II) metalorganic frameworks {Fe(4-PhPy)(2)[M(II)(CN)(x)](y)}.sH(2)O: spectroscopic, structural, and magnetic studies. | 2009 Jul 6 |
|
| Decreased susceptibility of the cytochrome P450 2B6 variant K262R to inhibition by several clinically important drugs. | 2009 Mar |
|
| Heptacarbonyl-1κC,2κC-(4-phenyl-pyridine-1κN)di-μ-phenyltellurido-1:2κTe:Te-dirhenium(I). | 2010 Apr 14 |
|
| Bis(μ-phenyl-tellurido-κTe:Te)bis-[tetra-carbonyl-rhenium(I)]. | 2010 Apr 24 |
|
| Excited-state properties of octahedral hexarhenium(III) complexes with redox-active N-heteroaromatic ligands. | 2010 Jan 18 |
|
| Tripodal 4-pyridyl-derived host ligands and their metallo-supramolecular chemistry: stella octangula and bowl-shaped assemblies. | 2010 Jan 18 |
|
| Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes. | 2010 May |
|
| Synthesis and structural and magnetic characterisation of cobalt(ii) complexes of mixed phosphonate-antimonate ligands. | 2010 Oct 28 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:36:08 UTC 2023
by
admin
on
Fri Dec 15 19:36:08 UTC 2023
|
| Record UNII |
452KD9YCG7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
452KD9YCG7
Created by
admin on Fri Dec 15 19:36:08 UTC 2023 , Edited by admin on Fri Dec 15 19:36:08 UTC 2023
|
PRIMARY | |||
|
13651
Created by
admin on Fri Dec 15 19:36:08 UTC 2023 , Edited by admin on Fri Dec 15 19:36:08 UTC 2023
|
PRIMARY | |||
|
939-23-1
Created by
admin on Fri Dec 15 19:36:08 UTC 2023 , Edited by admin on Fri Dec 15 19:36:08 UTC 2023
|
PRIMARY | |||
|
70375
Created by
admin on Fri Dec 15 19:36:08 UTC 2023 , Edited by admin on Fri Dec 15 19:36:08 UTC 2023
|
PRIMARY | |||
|
77935
Created by
admin on Fri Dec 15 19:36:08 UTC 2023 , Edited by admin on Fri Dec 15 19:36:08 UTC 2023
|
PRIMARY | |||
|
C051448
Created by
admin on Fri Dec 15 19:36:08 UTC 2023 , Edited by admin on Fri Dec 15 19:36:08 UTC 2023
|
PRIMARY | |||
|
213-357-4
Created by
admin on Fri Dec 15 19:36:08 UTC 2023 , Edited by admin on Fri Dec 15 19:36:08 UTC 2023
|
PRIMARY | |||
|
DTXSID5022140
Created by
admin on Fri Dec 15 19:36:08 UTC 2023 , Edited by admin on Fri Dec 15 19:36:08 UTC 2023
|
PRIMARY |